Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis - Delbaldo, C; Michiels, S; Syz, N; Soria, J C; Le Chevalier, T; Pignon, J P (JAMA, 2004)